Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ohe

Showing results (111-120 of 191) with videos related to

Pageof 20
Sort By:
ESMO Open|May 15, 2024
Patient-reported outcomes with selpercatinib treatment in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trialL E Raez, H Kang, Y Ohe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatinY Sasaki, T Tamura, K Eguchi, et al.
Japanese Journal of Clinical Oncology|October 1, 1994
Preliminary evaluation of the new tumor marker, CYFRA 21-1, in lung cancer patientsH Koga, K Eguchi, T Shinkai, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trialsN Saijo, K Nishio, N Kubota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1991
[Feasibility study of quality of life (QOL) instrument in patients with advanced lung cancer]M Fukutani, K Eguchi, Y Tanaka, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1990
Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancerK Eguchi, T Shinkai, Y Sasaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1990
[Bone marrow transplantation for MDS]N Inoue, Y Takemoto, T Okamoto, et al.
Japanese Journal of Clinical Oncology|January 13, 2001
Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408M Fujishiro, T Shinkai, M Fukuda, et al.
Japanese Journal of Clinical Oncology|August 1, 1991
Analysis of three-year survivors among patients with advanced inoperable non-small cell lung cancerA Kojima, T Shinkai, K Eguchi, et al.
Cancer Research|May 15, 1994
Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancerT Shinkai, H Arioka, H Kunikane, et al.
Pageof 20

Showing results (111-120 of 191) with videos related to

Sort By:
Pageof 20
ESMO Open|May 15, 2024
Patient-reported outcomes with selpercatinib treatment in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trialL E Raez, H Kang, Y Ohe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatinY Sasaki, T Tamura, K Eguchi, et al.
Japanese Journal of Clinical Oncology|October 1, 1994
Preliminary evaluation of the new tumor marker, CYFRA 21-1, in lung cancer patientsH Koga, K Eguchi, T Shinkai, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trialsN Saijo, K Nishio, N Kubota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1991
[Feasibility study of quality of life (QOL) instrument in patients with advanced lung cancer]M Fukutani, K Eguchi, Y Tanaka, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1990
Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancerK Eguchi, T Shinkai, Y Sasaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1990
[Bone marrow transplantation for MDS]N Inoue, Y Takemoto, T Okamoto, et al.
Japanese Journal of Clinical Oncology|January 13, 2001
Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408M Fujishiro, T Shinkai, M Fukuda, et al.
Japanese Journal of Clinical Oncology|August 1, 1991
Analysis of three-year survivors among patients with advanced inoperable non-small cell lung cancerA Kojima, T Shinkai, K Eguchi, et al.
Cancer Research|May 15, 1994
Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancerT Shinkai, H Arioka, H Kunikane, et al.
Pageof 20